Cargando…

P34.06 Antiproliferative Effects of Paclitaxel on PC9-MET Cells During the Coronavirus Disease 2019 Pandemic

Detalles Bibliográficos
Autores principales:	Mohiuddin, M., Kasahara, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523165/ http://dx.doi.org/10.1016/j.jtho.2021.08.423

Ejemplares similares

P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P34.01 6-Weekly vs 3-Weekly Pembrolizumab – Toxicities and Tolerance in The COVID-era
por: Douglas, C., et al.
Publicado: (2021)

P34.03 Lung Cancer Patients and COVID-19 in a District General Hospital in the UK
por: Aujayeb, A.
Publicado: (2021)

P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
por: Olson, E., et al.
Publicado: (2021)

P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study
por: Ospina Serrano, A.V., et al.
Publicado: (2021)

P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre
por: Petersen, L., et al.
Publicado: (2021)

P32.01 Clinical Screening for COVID-19 in Asymptomatic Patients With Lung Cancer: Brazilian Experience From a Single Institution
por: Teixeira, C.H., et al.
Publicado: (2021)

FP06.03 COVID-19: Does Thoracic Surgery Increase Mortality Rates during the Pandemic?
por: Tsukazan, M.T., et al.
Publicado: (2021)

FP06.02 The Impact of The COVID-19 Pandemic on New Diagnoses of Lung Cancer: A 3-Year Review of an Irish Cancer Centre
por: Carroll, H., et al.
Publicado: (2021)

P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review
por: Kasymjanova, G., et al.
Publicado: (2021)

P31.05 SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management
por: Tsukazan, M.T., et al.
Publicado: (2021)

P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021)

P31.04 Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study
por: Patel, A., et al.
Publicado: (2021)

P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients
por: Araujo, A., et al.
Publicado: (2021)

P33.01 Air Leak Due COVID-19 in a Lung Cancer Patient
por: Aujayeb, A.
Publicado: (2021)

EP06.01-007 Fate of Pneumonectomy Patients During Covid-19 Pandemic
por: Güler, G., et al.
Publicado: (2022)

EP06.01-014 Lung Resections After COVID: Short-term Outcomes
por: Kodaganur Gopinath, S., et al.
Publicado: (2022)

EP06.01-003 Impact of COVID-19 on Lung Cancer Patients; The Patients’ Perspective
por: Samnani, S., et al.
Publicado: (2022)

EP06.01-009 Maintaining Thoracic Services During COVID-19 - A Single Centre Experience
por: Walji, H.D., et al.
Publicado: (2022)

EP06.01-016 Nationwide Activity of Lung Cancer Surgery Before and During the COVID-19 Pandemic
por: Laisaar, T., et al.
Publicado: (2022)

EP06.01-006 Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis
por: Ramella, S., et al.
Publicado: (2022)

EP06.01-004 Lung Cancer Resection During the Covid-19 Pandemic: A Single Centre Study
por: Oyebanji, T.N., et al.
Publicado: (2022)

EP06.01-002 Cancer Care in a Time of COVID: Lung Cancer Patient’s Experience of Telehealth and Connectedness.
por: Fraser, A.
Publicado: (2022)

EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
por: Garitaonaindía Díaz, Y., et al.
Publicado: (2022)

EP06.01-012 Impact of COVID-19 on the Stage of Lung Cancer Diagnosis at the Mohamed VI Center for Cancer Treatment in Morocco
por: Panandtigri, S., et al.
Publicado: (2022)

EP06.01-005 COVID-19 and Post-COVID Outcomes in Lung Cancer Patients: Experience from an Indian Cancer Center
por: Mondal, D., et al.
Publicado: (2022)

EP06.01-013 Differences of Oncology Treatment for Lung Cancer Patients in Pandemic COVID-19 Year: Our Clinical Experience
por: crvenkova, s., et al.
Publicado: (2022)

EP06.01-015 Will Virtual Care Stand the Test of Time; One Site’s Perspective on the Continuity of Virtual Care Post-Pandemic
por: Lee, S., et al.
Publicado: (2022)

EP06.01-008 COVID-Protected Pathways for Image Guided Lunc Cancer Intervention During the COVID-19 Pandemic: A Cohort Study
por: Sheeka, A., et al.
Publicado: (2022)

EP06.01-011 COVID-19 Impact in Thoracic Surgery: a Comparison Between Public and Private Care in a Single-Center Facility
por: Casanova Schulze, P.A., et al.
Publicado: (2022)

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
por: Marrone, Kristen A., et al.
Publicado: (2018)

EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review
por: Rizzolo, A., et al.
Publicado: (2022)

EP06.01-010 Clinical Outcomes after Hypo Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer During The Covid-19 Pandemic In Morocco
por: cherkaoui, M., et al.
Publicado: (2022)

CRT-200.06 Cardiovascular Outcomes of Congestive Heart Failure on COVID-19 Hospitalizations: A Nationwide Analysis
por: Varlan, Doina, et al.
Publicado: (2023)

Preventing the Spread: A Comprehensive Cancer Center’s Journey to Prevent the Spread of Coronavirus Disease (Covid-19) During the 2020 Pandemic
por: Carraway, Stephanie, et al.
Publicado: (2021)

CRT-200.06 Impact of the COVID-19 Pandemic on Cardiology Services and Catheterization Volumes in the Second Year: A Comparison of 2020 and 2021 at a South Asian Cardiac Centre
por: Cader, F. Aaysha, et al.
Publicado: (2022)

La négativité persistante des prélèvements nasopharyngés est-elle fiable pour éliminer une pneumonie au SARS-CoV-2 chez un patient en quarantaine post-exposition ?
por: Benech, N., et al.
Publicado: (2020)

Spécificités des pneumopathies acquises sous ventilation mécanique chez les patients atteints de COVID-19 (CPAVM) : comparaison avec une cohorte historique de PAVM non COVID (NCPAVM)
por: Rouyer, M., et al.
Publicado: (2021)

Évolution des patients à très haut risque ayant reçu du Sotrovimab pour un COVID-19 Omicron léger à modéré dans la cohorte ANRS 0003S CoCoPrev
por: Martin-Blondel, G, et al.
Publicado: (2022)

Is investigation of patients with haemoptysis and normal chest radiograph justified?
por: Thirumaran, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_v1g83ebenliujq1nft323094ir